FAF vs IONS · P/E 10, rev $6.13B vs rev $226.6M
First American Corporation (FAF) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
First American Corporation (FAF) is a insurance - specialty company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported FAF revenue for 2024-12-31 was $6.13B. Net income was $132.6M. Revenue was up 2.1% from 2023-12-31 to 2024-12-31. FAF currently screens at market cap $6.83B and trailing P/E 10.3.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
FAF currently screens at market cap $6.83B and trailing P/E 10.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the FAF and IONS stock pages for the full models.
Not investment advice.